What class of drug does tofacitinib belong to?
Aug 26, 2023
Source: Cainiu Health
Dr. Yang Shuwen
Introduction
Under normal circumstances, tofacitinib refers to tofacitinib citrate tablets, which belong to the class of anti-rheumatic drugs. Tofacitinib citrate tablets can modulate cellular immunity and are a novel oral protein tyrosine kinase inhibitor, providing anti-rheumatic effects; thus, they are classified as anti-rheumatic agents. Patients must strictly follow medical instructions when taking tofacitinib citrate tablets and should not self-medicate.
Under normal circumstances, tofacitinib refers to tofacitinib citrate tablets, which belong to the class of anti-rheumatic drugs. The specific analysis is as follows:
Tofacitinib citrate tablets can modulate cellular immunity and are a novel oral protein tyrosine kinase inhibitor, providing anti-rheumatic effects; therefore, they are classified as anti-rheumatic drugs. Tofacitinib citrate tablets help improve joint lesions caused by rheumatic conditions, relieve joint pain, and effectively control disease progression.
Currently, there are no significant known contraindications for tofacitinib citrate tablets, but pregnant women, lactating women, elderly individuals, and children should use the drug with caution. Major adverse reactions include increased risk of serious infections, malignancies and lymphoproliferative disorders, gastrointestinal perforation, lymphopenia, neutropenia, elevated liver enzymes, and increased blood lipid levels.
Patients must strictly follow medical instructions when taking tofacitinib citrate tablets and should not self-administer the medication.
